NASDAQ:MRKR

Marker Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy MRKR

*Your capital is at risk

$1.45

+0.0300 (+2.11%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

MRKR Prediction Chart

MRKR Predictions History

Latest community submissions for MRKR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
You Decide Say What @YouDecideSayWhat.207513	Apr 5, 2021	Bearish	$2.24	V	—	0
geordiecrew77 Amateur	Apr 5, 2021	$2.30 -89.73%	$2.24	X	97.32%	1
JS Pro	Mar 22, 2021	$2.52 -91.19%	$2.86	X	88.11%	1
Sebastian Burgos @SebastianBurgos.214306	Mar 22, 2021	Bullish	$2.86	X	—	1
JS Pro	Jul 2, 2019	$7.89 -89.97%	$7.87	V	99.75%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MRKR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT MARKER THERAPEUTICS INC.

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by